Alkermes Shares Mental Health Resources During National Suicide Prevention Month

Alkermes Shares Mental Health Resources During National Suicide Prevention Month

Monday, September 21, 2020 - 11:45am

CAMPAIGN: Alkermes Medicines & Focus: Serious Mental Illness

CONTENT: Multimedia with summary

Did you know that over 50% of individuals with #schizophrenia who die by suicide have made a previous attempt?

September is National Suicide Prevention Month, and National Suicide Prevention Lifeline provides 24/7, free and confidential support.

About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts ; a research and manufacturing facility in Athlone, Ireland ; and a manufacturing facility in Wilmington, Ohio . For more information, please visit Alkermes' website at www.alkermes.com.